Recombinant BCG strains with enhanced ability to escape the endosome

Details for Australian Patent Application No. 2005338353 (hide)

Owner Aeras Global TB Vaccine Foundation

Inventors Hone, David Michael; Sadoff, Jerald C.; Sun, Ronggai

Agent Halfords IP

Pub. Number AU-B-2005338353

PCT Pub. Number WO2007/058663

Priority 60/631,973 01.12.04 US

Filing date 23 November 2005

Wipo publication date 24 May 2007

Acceptance publication date 14 April 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A01N 63/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2007/058663 Priority application(s): WO2007/058663

14 April 2011 Application Accepted

  Published as AU-B-2005338353

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005338370-Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same

2005338352-Method for field scale production optimization